# TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography

> **NCT01972022** · PHASE4 · UNKNOWN · sponsor: **A.O. Ospedale Papa Giovanni XXIII** · enrollment: 90 (estimated)

## Conditions studied

- Coronary Artery Lesions

## Interventions

- **DEVICE:** EES SYNERGY™
- **DEVICE:** ZES, RESOLUTE Integrity™

## Key facts

- **NCT ID:** NCT01972022
- **Lead sponsor:** A.O. Ospedale Papa Giovanni XXIII
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2015-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01972022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01972022, "TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01972022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*